Cancer BiologybioRxivPreprint
The antiangiogenic compound axitinib demonstrates low toxicity and anti-tumoral effects against medulloblastoma
M. Pagnuzzi-Boncompagni, V. Picco, V. Vial…·G. Pages
This study evaluates axitinib's efficacy and safety in medulloblastoma, finding it has low toxicity and anti-tumoral effects in preclinical models and poor prognosis association in public databases.
DOI 10.1101/2020.09.18.301028